Therapiezentrum findenTherapiezentrum finden
Investor Room Investor Room
neurocare group announces MDMA approval of TMS Devices in Saudi Arabia
neurocare group has received approval to market its TMS devices in Saudi Arabia, marking a significant advancement in mental health...
NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions
NRx Pharmaceuticals and neurocare Group AG launch a nationwide program integrating TMS, medications, and psychotherapy to treat Depression,...
neurocare group's Apollo TMS Therapy Devices Now Have FDA Clearance to Treat Adolescents Suffering With Major Depression
FDA clears neurocare group's Apollo TMS Therapy for adolescent depression, offering a safe, non-invasive alternative to traditional...
neurocare group receives FDA clearance for treatment of OCD with its Transcranial Magnetic Stimulation (TMS) devices
Leadership continuity positions neurocare for its next decade of global expansion, innovation, and patient impact.

Kontakt

Kontaktieren Sie uns, um mehr über Innovationen in den Bereichen Mental Health und Performance zu erfahren

Kontakt Kontakt